Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Contraceptive Implant Hails New Era of Birth Control

By HospiMedica International staff writers
Posted on 22 Jul 2014
A fingernail-sized implant holds enough 30-microgram daily doses of levonorgestrel to provide contraception for 16 years.

Developed by MicroCHIPS (Lexington, MA, USA), a MIT (Cambridge, MA, USA) startup, the device, which measures just 20 x 20 x 7 millimeters, is designed to be implanted under the skin of the buttocks, upper arm, or abdomen. It then dispenses a daily dose levonorgestrel from a reservoir sealed with a titanium and platinum hermetic stopper. Passing an electric current through the stopper melts it temporarily, allowing a 30-microgram dose of the hormone to diffuse out each day.

Women who receive the implant also get a remote control that allows them to halt or restart the implant on demand; to conceive, women turn off the implant with a remote control; another click of the remote restarts it. Doctors could also adjust dosages remotely. MicroCHIPS have previously demonstrated how the microchip technology could release daily doses of an osteoporosis drug. The new application could revolutionize the level of control women have over their birth control technologies.

The technology also includes a secure encryption protocol to prevent outsiders from blocking or reprogramming the implants wirelessly. Another safety factor is that the device is triggered remotely by radio communication over a special frequency called Medical Implant Communication Service (MICS), which only works over a very short distance, almost requiring skin contact to function. The device will begin preclinical testing in the US in 2015, with the goal of market approval by 2018. The study describing the technology was published on July 4, 2014, in MIT Technology Review.

“The idea of using a thin membrane like an electric fuse was the most challenging and the most creative problem we had to solve,” said Robert Farra, president of MicroCHIPS. “We have heard a lot of positive feedback. Women are excited about the capability to change the state of an implant without having to go through another procedure to have it removed. They like the long-term medication, and not having to remember to take medication each day.”

Related Links:
MicroCHIPS
MIT



Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
4K-3D NIR/ICG Video Endoscope
TIPCAM 1 Rubina
New
Double Door Pharmacy Refrigerator
iPR256-GX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new technology can make heart-related predictions more widely accessible through the use of wearables (Photo courtesy of Fred Zwicky/UIUC)

Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery

The heart's response to physical activity is a vital early indicator of changes in health, particularly in cardiovascular function and mortality. Extensive research has demonstrated a connection between... Read more

Surgical Techniques

view channel
Image: The diffusion model was trained on real LGE-MRI distributions and generated synthetic fibrosis distributions from Gaussian noise (Photo courtesy of Frontiers, DOI: 10.3389/fcvm.2025.1512356)

AI-Generated Synthetic Scarred Hearts Aid Atrial Fibrillation Treatment

Atrial fibrillation (AF) is a common heart rhythm disorder, often linked to the development of fibrosis, which is the formation of scar tissue in the heart. This fibrosis typically arises due to aging,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.